 |
|
UNC medical geneticist cautions against rushing into genetic testing
June 02, 2008CHAPEL HILL - Just because scientific advances now allow individuals to learn their genetic make-up doesn't mean they should rush into genetic testing in hopes of making revolutionary improvements to their health, cautions a geneticist and practicing physician at the University of North Carolina at Chapel Hill.
"From a basic science perspective, the advances being made in genomics are important discoveries, but it's unrealistic for individuals to believe those advances can yield meaningful information that will improve their health," said James P. Evans, M.D., Ph.D., professor of genetics and medicine in the UNC School of Medicine. "And even saying 'It's not there yet' is too optimistic. It's going to be a long time before the potential is realized."
Evans, who is also the director of the cancer and adult genetics clinics and the Bryson Program in Human Genetics in UNC's medical genetics department, will talk about how personal genomics will affect human lives at a panel discussion titled "Your Biological Biography" at the World Science Festival (www.worldsciencefestival.com) being held in New York City, May 28 to June 1. Evans will speak between 1 p.m. and 2:30 p.m. on Saturday, May 31, at the Kimmel Center for University Life at New York University.
"The sequencing of the human genome revealed that in relative terms, humans are 99.9 percent the same," Evans said. "But in absolute terms, we are very different. For example, a one-thousandth of a difference in their respective DNA profiles translates into more than 3 million differences between any two unrelated individuals."
Some of these differences are medically relevant, in that they influence disease predisposition and response to drugs, areas Evans studies in his research. And the differences are of interest in non-medical ways, specifically when they address ancestry, behavior traits and the innate curiosity humans have about their genes.
Sequencing of the human genome, which was completed in 2003, also gave rise to commercial entities offering direct-to-consumer genetic testing for a fee, usually between $1,000 and $3,000. Evans worries that individuals may seek such testing with the false hope that they will get meaningful results regarding their risks for disease and actionable medical advice about how to decrease their risks.
"Much of the current excitement about genetics and medical genomics is predicated on the idea that knowing our genomes better will improve our health," Evans said. "In fact, for the vast majority of such risk assessments, the increased risk of an individual developing the disease in question is modest - one- to two-fold over baseline. And in few such conditions are there specific effective interventions to diminish the risk. Further, there is little evidence that having the specific genetic information would actually induce a change in lifestyle."
Society has tended to place an almost mystical association on genetic information, Evans said, adding that what to do with this new knowledge and how to interpret the information presents many unanswered challenges.
"Most physicians, by their own admission, are not geneticists and won't know what to do with the information," said Evans, who uses family history and genetic testing to evaluate and counsel patients about their risk for cancer. "Many who do understand the technology and how it is generated don't know what to do with it. So there's huge potential for patient harm - either for patients to be lulled into a false sense of security by this new genomic information or, in the opposite extreme, to have unnecessarily increased anxiety."
And Evans said he can see even more extreme measures "where interventions are implemented - for example, a total body scan - that put patients on a road to invasive tests that they are better off not getting."
Evans believes these challenges say something about how humans value information, but then fail to scrutinize what it really means. "It's hard for me to over-estimate the beauty and utter significance of sequencing the human genome and other animal genomes," Evans said. "The technology is very promising for all of us, but there is a big gap between having that knowledge and applying it for the betterment of human health."
University of North Carolina at Chapel Hill
"The sequencing of the human genome revealed that in relative terms, humans are 99.9 percent the same," Evans said. "But in absolute terms, we are very different. For example, a one-thousandth of a difference in their respective DNA profiles translates into more than 3 million differences between any two unrelated individuals."
Some of these differences are medically relevant, in that they influence disease predisposition and response to drugs, areas Evans studies in his research. And the differences are of interest in non-medical ways, specifically when they address ancestry, behavior traits and the innate curiosity humans have about their genes.
Sequencing of the human genome, which was completed in 2003, also gave rise to commercial entities offering direct-to-consumer genetic testing for a fee, usually between $1,000 and $3,000. Evans worries that individuals may seek such testing with the false hope that they will get meaningful results regarding their risks for disease and actionable medical advice about how to decrease their risks.
"Much of the current excitement about genetics and medical genomics is predicated on the idea that knowing our genomes better will improve our health," Evans said. "In fact, for the vast majority of such risk assessments, the increased risk of an individual developing the disease in question is modest - one- to two-fold over baseline. And in few such conditions are there specific effective interventions to diminish the risk. Further, there is little evidence that having the specific genetic information would actually induce a change in lifestyle."
Society has tended to place an almost mystical association on genetic information, Evans said, adding that what to do with this new knowledge and how to interpret the information presents many unanswered challenges.
"Most physicians, by their own admission, are not geneticists and won't know what to do with the information," said Evans, who uses family history and genetic testing to evaluate and counsel patients about their risk for cancer. "Many who do understand the technology and how it is generated don't know what to do with it. So there's huge potential for patient harm - either for patients to be lulled into a false sense of security by this new genomic information or, in the opposite extreme, to have unnecessarily increased anxiety."
And Evans said he can see even more extreme measures "where interventions are implemented - for example, a total body scan - that put patients on a road to invasive tests that they are better off not getting."
Evans believes these challenges say something about how humans value information, but then fail to scrutinize what it really means. "It's hard for me to over-estimate the beauty and utter significance of sequencing the human genome and other animal genomes," Evans said. "The technology is very promising for all of us, but there is a big gap between having that knowledge and applying it for the betterment of human health."
University of North Carolina at Chapel Hill
Genetic Testing News and Current Genetic Testing Events RSSGenetic testing?
Frequently, autopsy becomes the principal diagnostic tool when macro and microscopic analyses provide a conclusive diagnosis in cardiomyopathies.
No need for gene screens in breast cancer families
Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal BMC Cancer shows that a family history of breast cancer does not give a useful indication of the likelihood that a woman will develop it herself at an early age.
Predicting the risk of a common fungal infection after stem cell transplantation
In silico genetic analysis in mice has led to the discovery of a gene affecting susceptibility to a severe fungal infection in transplant recipients.
Inherited melanoma risk: What you do know does help you
When people know the results of genetic tests confirming they have inherited an increased risk of developing melanoma, they follow skin cancer screening recommendations more proactively-much like those who have already been diagnosed with the potentially deadly disease.
Study finds it pays to be heart smart if considering hormone therapy
A research study has found that a simple blood test may indicate whether post-menopausal hormone therapies present an elevated risk of a heart attack.
Study Shows Gene Variations May Predict Risk of Breast Cancer in Women
According to a recent study, led by Virginia Kaklamani, MD, an oncologist at Northwestern Memorial Hospital and assistant professor of medicine, Northwestern University Feinberg School of Medicine, variations of the adiponectin gene, which regulates a number of metabolic processes, may increase a woman's risk of developing breast cancer.
Second breast cancer may be greater than thought for high-risk women without BRCA mutations
A preliminary analysis of ongoing research suggests that high-risk women with breast cancer who do not have a BRCA1/2 mutation may face a greater chance for developing a second breast cancer than previously thought. With the increased risk of cancer in these women, should sentinel node biopsy be considered at the time of prophylactic mastectomy, and how can women best be counseled after these findings?
American College of Medical Genetics makes genetic testing recommendations in new policy statement
Consumers are increasingly being marketed a broad range of genetic tests. Paternity tests at the drugstore-.Personal genome mapping-Gene tests to predict future baldness.
High anxiety?
Right now, about half of all people who take medicine for an anxiety disorder don't get much help from it. And doctors have no definitive way to predict who will, and who won't, benefit from each anti-anxiety prescription they write.
Many African-Americans have a gene that prolongs life after heart failure
About 40 percent of African-Americans have a genetic variant that can protect them after heart failure and prolong their lives, according to research conducted at Washington University School of Medicine in St. Louis and collaborating institutions.
More Genetic Testing News Articles
 | It's Not Just Your Genes! by Ruth DeBusk, Yael Joffe It's Not Just Your Genes! introduces you to the fascinating world of genomics. Genetic technologies are revolutionizing health care, and in order to take full advantage of the advances emerging from this field, you need to get comfortable with its language and concepts. Today we know that rather than viewing our genetic makeup as a hand of cards that have already been dealt, we have the power... |
 | The Rising Curve: Long-Term Gains in IQ and Related Measures (Apa Science Volumes) ...written by leading experts in psychology, sociology, psychometrics, and nutrition...discusses the environmental and social factors that affect IQ, the upward trend in IQ scores worldwide, and much... |
 | Multiple Testing Procedures with Applications to Genomics (Springer Series in Statistics) by Sandrine Dudoit, Mark J. van der Laan This book establishes the theoretical foundations of a general methodology for multiple hypothesis testing and discusses its software implementation in R and SAS. The methods are applied to a range of testing problems in biomedical and genomic research, including the identification of differentially expressed and co-expressed genes in high-throughput gene expression experiments, such as... |
 | Genetic Ties and the Family: The Impact of Paternity Testing on Parents and Children Genetic Ties and the Family brings together experts in history, law, ethics, philosophy, psychology, social work, and sociology to explore the tension between biological and social conceptions of parentage. The contributors consider the effect of DNA-based paternity testing on family relationships and discuss the ethical, legal, and social implications.These essays reflect the changing concepts... |
 | Quality of Life and Human Difference: Genetic Testing, Health Care, and Disability (Cambridge Studies in Philosophy and Public Policy) The role of quality assessments in social policy, especially health policy, and ethical and social issues raised by prenatal testing for disability are discussed in this analysis. A theme of the literature has been the role played by controversial assumptions about the quality of life of people with disabilities. This book turns the perspectives of disability scholars to issues that have largely... |
 | Infancy to Early Childhood: Genetic and Environmental Influences on Developmental Change Behavioral genetics is a fast-growing, multidisciplinary field which attempts to explain the influence of genetic and environmental factors on behavior through the lifespan. The preferred investigative technique for teasing out the differences between genetics and the environment is the longitudinal twin study. This book is the first complete publication from the MacArthur Longitudinal Twin Study... |
 | The Moral, Social, and Commercial Imperatives of Genetic Testing and Screening: The Australian Case (International Library of Ethics, Law, and the New Medicine) This is a dynamic book that successfully combines global and local thinking with regard to an emerging technology that will contribute to the expansion of proteomics and pharmacogenomics, the science of tailored healthcare and treatments. Genetic testing and screening will change the way people understand health, diagnostic knowledge, illness but also crime, databases and private information,... |
 | 21st Century Complete Guide to Genetics and Preventive Medicine: CDC Programs on Chronic Disease Prevention, Human Genome Epidemiology, Case Studies on ... Families, Genetic Testing and Public Health by PM Medical Health News This electronic book on CD-ROM presents comprehensive information on two vital medical subjects: the incredible field of genomics and disease prevention, and the ongoing effort at chronic disease prevention through risk factor reduction and surveillance. Extensive material from the Centers for Disease Control (CDC), the National Institute of General Medical Sciences, and the President's Council... |
 | Practical Laboratory Andrology by David Mortimer This practical manual on sperm analysis presents the diagnostic and therapeutic procedures that are used in andrology laboratories to analyze and assess male infertility. Diagnostic areas include: semen analysis and the biochemical, immunological and microbiological examination of human semen and spermatozoa; computer-aided sperm motility analysis; sperm ultrastructure; and assessment of sperm... |
 | Who is Really Who?: The Comprehensive Guide to DNA Paternity Testing by Avi Lasarow The need to establish who is the biological father of a child arises in many situations, some pleasant, and others less so. But whatever our reasons for undergoing such a test, we need to feel sure of what we are getting into and be certain that we are receiving the best treatment. This clear, no-nonsense book covers every aspect of the process, explaining what a DNA test is, and how accurate it... |
| © 2008 BrightSurf.com |